You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 156 No. 5, 11 MARCH 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL OBSERVATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Malacoplakia

Two Case Reports and a Comparison of Treatment Modalities Based on a Literature Review

Peter H. J. van der Voort, MD; Jos J. A. M. ten Velden, MD; Ronald P. Wassenaar, MD; Joseph Silberbusch, PhD, MD

Arch Intern Med. 1996;156(5):577-583.


Abstract



Malacoplakia is a rare infectious disease that has been almost exclusively reported in urology and pathology journals. We studied two cases of malacoplakia that were primarily referred to the department of internal medicine because of fever and abdominal masses. In one patient, malacoplakia was diagnosed in the unusual ovarian location, while in the other patient a large renal mass was found and ciprofloxacin therapy failed because of bacterial resistance. The clinical and radiologic appearance of malacoplakia often mimics that of a malignant tumor. The principal disorder is probably a monocytic-macrophagic bactericidal defect. A definitive diagnosis depends on microscopic detection of Michaelis-Gutmann bodies by means of von Kossa stain. We outlined treatment strategies on the basis of a review of the literature since 1981, which included 140 cases. If possible, immunosuppressive drugs should be stopped. Quinolone antibiotic treatment and surgical excision or incision and drainage lead to the highest cure rates (90% and 81%, respectively). Specific intracellular penetration of quinolone antibiotics is a possible reason for the higher cure rate achieved with these antibiotics. Bethanechol has been suggested to correct the supposed fundamental disturbance by increasing the intracellular cyclic guanosine monophosphate concentration, but there is still no convincing evidence of its clinical efficacy.

(Arch Intern Med. 1996;156:577-583)



Author Affiliations



From the Departments of Internal Medicine (Drs van der Voort and Silberbusch), Pathology (Dr ten Velden), and Radiology (Dr Wassenaar), Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Malakoplakia of the Spleen: A Case Report
Greaves and Wang
INT J SURG PATHOL 2010;18:584-587.
ABSTRACT  

Malakoplakia of the Prostate on Needle Core Biopsy: A Case Report and Review of the Literature
Wagner et al.
INT J SURG PATHOL 2007;15:86-89.
ABSTRACT  

MRI appearances of pelvic malakoplakia
Gopal et al.
Br. J. Radiol. 2006;79:e205-e207.
ABSTRACT | FULL TEXT  

Malacoplakia Presenting as a Solitary Renal Mass
Wielenberg et al.
Am. J. Roentgenol. 2004;183:1703-1705.
FULL TEXT  

Bilateral renal parenchymal malakoplakia presenting as haemolytic–uraemic syndrome
Hong et al.
Nephrol Dial Transplant 1999;14:2206-2209.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.